Actively Recruiting

Phase 4
Age: 1Month - 36Months
All Genders
Healthy Volunteers
NCT03384563

Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane

Led by Baylor College of Medicine · Updated on 2025-09-22

180

Participants Needed

1

Research Sites

410 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this protocol is to determine the effect of two clinically applicable Dexmedetomidine dosages (0.5mcg/kg and 1mcg/kg) on the minimum alveolar concentration (MAC) of Sevoflurane in children between the age ranges of: 1-6 months; 6-12 months of age and 12 months-36 months years of age.

CONDITIONS

Official Title

Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane

Who Can Participate

Age: 1Month - 36Months
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 1 month to 3 years presenting for surgery
Not Eligible

You will not qualify if you...

  • Interstitial lung disease, chest wall disease, or bronchospastic disease with flare-ups in the past 2 weeks
  • History of difficult intubation or ventilation
  • Airway malformation
  • Congenital heart disease
  • Cardiac arrhythmias
  • Central nervous system disease including developmental delay, cerebral palsy, or seizure disorder
  • History of or family history of malignant hyperthermia
  • Electrolyte disorders
  • Gastrointestinal disease
  • Hepatic dysfunction
  • Renal dysfunction
  • Metabolic diseases such as diabetes
  • Obesity defined as body mass index greater than the 95th percentile for age
  • Preterm infant (less than 37 weeks gestational age)
  • Use of medications that may affect MAC, including anticonvulsants, opioids, benzodiazepines, antibiotics, antihistamines, or drugs that induce hepatic enzymes

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Texas Children's Hospital

Houston, Texas, United States, 77030

Actively Recruiting

Loading map...

Research Team

M

Margaret Owens-Stuberfield

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

SINGLE_GROUP

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

9

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here